Advertisement
Canada markets close in 22 minutes
  • S&P/TSX

    22,298.23
    +54.89 (+0.25%)
     
  • S&P 500

    5,302.78
    +56.10 (+1.07%)
     
  • DOW

    39,865.62
    +307.51 (+0.78%)
     
  • CAD/USD

    0.7352
    +0.0027 (+0.36%)
     
  • CRUDE OIL

    78.78
    +0.76 (+0.97%)
     
  • Bitcoin CAD

    89,788.91
    +6,073.30 (+7.25%)
     
  • CMC Crypto 200

    1,388.32
    +120.38 (+9.51%)
     
  • GOLD FUTURES

    2,392.40
    +32.50 (+1.38%)
     
  • RUSSELL 2000

    2,107.09
    +21.39 (+1.03%)
     
  • 10-Yr Bond

    4.3560
    -0.0890 (-2.00%)
     
  • NASDAQ

    16,737.40
    +226.22 (+1.37%)
     
  • VOLATILITY

    12.53
    -0.89 (-6.63%)
     
  • FTSE

    8,445.80
    +17.67 (+0.21%)
     
  • NIKKEI 225

    38,385.73
    +29.67 (+0.08%)
     
  • CAD/EUR

    0.6753
    -0.0016 (-0.24%)
     

Valeant gives Pershing Square a seat on its board

The headquarters of Valeant Pharmaceuticals International Inc., seen in Laval, Quebec November 9 2015.  REUTERS/Christinne Muschi
The headquarters of Valeant Pharmaceuticals International Inc., seen in Laval, Quebec November 9 2015. REUTERS/Christinne Muschi

Thomson Reuters

(Reuters) - Valeant Pharmaceuticals International Inc , under scrutiny for its accounting and business practices, said it had given shareholder Pershing Square Capital Management a seat on its board and added two additional directors.

Stephen Fraidin, a veteran Wall Street lawyer who is vice chairman at William Ackman's Pershing Square, has joined the board, along with Fred Eshelman and Thomas Ross, Valeant said.

Anders Lonner has stepped down as a director, the company said on Wednesday.

 

 

 

 

(Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)

See Also: